Mutasem Taha

Citat de

	Toate	Din 2020
Referințe bibliografice	5555	2586
h-index	41	22
i10-index	133	78

580

290

145

435

2006200720082009201020112012201320142015201620172018201920202021202220232024202525 39 97 80 116 184 228 233 247 264 412 326 261 334 371 466 552 568 517 107

Acces public

Afișați-le pe toate

13 articole

4 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Yasser BustanjiProfessor of Biochemistry and Clinical Chemistry, The University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Mahmoud Al-Sha'erZarqa University-Faculty of PharmacyAdresă de e-mail confirmată pe zu.edu.jo
Ma'mon M. Hatmal مأمون حتملVisiting Professor Stanford, Professor of Biochemistry and Molecular Biology Hashemite UniversityAdresă de e-mail confirmată pe hu.edu.jo
Khaled AiedehProfessor of PharmaceuticsAdresă de e-mail confirmată pe ju.edu.jo
Mohammad MohammadFaculty of Pharmacy, The University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Mohammad A KhanfarAlfaisal University - University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Malek ZihlifDepartment of Pharmacology, Faculty of Medicine, University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Maha HabashAqaba University of TechnologyAdresă de e-mail confirmată pe aut.edu.jo
Isra DmourThe Hashemite University, Faculty of Pharmaceutical SciencesAdresă de e-mail confirmată pe staff.hu.edu.jo
Amal G. Al-BakriProfessor of Pharmaceutical Microbiology, Faculty of Pharmacy, The University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Hiba ZalloumHamdi Mango Center for Scientific Research, The University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Mohamed GhusseinAssistant Professor of Biochemistry, Al Azhar University-GazaAdresă de e-mail confirmată pe alazhar.edu.ps
Hatim S. AlKhatibSchool of Pharmacy, University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Reema Abu KhalafAl-Zaytoonah University of JordanAdresă de e-mail confirmată pe zuj.edu.jo
Afaf H. AL-NadafMutah university ProfessorAdresă de e-mail confirmată pe mutah.edu.jo
Safa DaoudAssociate Professor, Faculty of Pharmacy, Applied Science Private UniversityAdresă de e-mail confirmată pe asu.edu.jo
Ahmad DisiProfessor , The University Of JordanAdresă de e-mail confirmată pe ju.edu.jo
Samer R. AbulateefehThe University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Lina A. DahabiyehProfessor of Bioanalysis and Biomarker Discovery, The University of JordanAdresă de e-mail confirmată pe ju.edu.jo
Walhan ALSHAERAssociate Professor, Al-Ahliyya Amman University and University of JordanAdresă de e-mail confirmată pe ammanu.edu.jo

Urmăriți

Mutasem Taha

Professor of Drug Design, University of Jordan

Adresă de e-mail confirmată pe ju.edu.jo - Pagina de pornire

Pharmaceutics Computer-Aided Molecular Design Medicinal Chemistry


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
Degradability of chitosan micro/nanoparticles for pulmonary drug delivery N Islam, I Dmour, MO Taha Heliyon 5, e01684, 2019	247	2019
Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine I Al-masri, KM Mohammad, MO Taha journal of enzyme inhibition and medicinal chemistry 24 (5), 1061-1066, 2009	230	2009
Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2 MM Hatmal, W Alshaer, MAI Al-Hatamleh, M Hatmal, O Smadi, MO Taha, ... Cells 9 (12), 2638, 2020	209	2020
Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon‐specific drug delivery systems K Aiedeh, MO Taha Archiv der pharmazie: an international journal pharmaceutical and medicinal …, 1999	180	1999
Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral … K Aiedeh, MO Taha European Journal of Pharmaceutical Sciences 13 (2), 159-168, 2001	134	2001
Stable Chitosan-Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles … R Saeed, I Dmour, M Taha Frontiers in Bioengineering and Biotechnology, 2020	126	2020
Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for … MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ... Journal of medicinal chemistry 51 (7), 2062-2077, 2008	121	2008
Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ... Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009	115	2009
Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis MA Abbas, MO Taha, AM Disi, M Shomaf European journal of pharmacology 715 (1-3), 72-75, 2013	114	2013
Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening MO Taha, Y Bustanji, AG Al-Bakri, AM Yousef, WA Zalloum, IM Al-Masri, ... Journal of Molecular Graphics and Modelling 25 (6), 870-884, 2007	109	2007
Sodium lauryl sulfate impedes drug release from zinc-crosslinked alginate beads: Switching from enteric coating release into biphasic profiles MO Taha, W Nasser, A Ardakani, HS AlKhatib International Journal of Pharmaceutics 350 (1-2), 291-300, 2008	90	2008
Enhanced drug encapsulation and extended release profiles of calcium–alginate nanoparticles by using tannic acid as a bridging cross-linking agent SR Abulateefeh, MO Taha Journal of microencapsulation 32 (1), 96-105, 2015	88	2015
Investigation of the active constituents of Portulaca oleraceae L.(Portulacaceae) growing in Jordan AN Rasheed, FU Afifi, M Shaedah, MO Taha Pakistan Journal of Pharmaceutical Sciences 17 (1), 37-45, 2004	87	2004
Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies MO Taha, M Habash, Z Al-Hadidi, A Al-Bakri, K Younis, S Sisan Journal of chemical information and modeling 51 (3), 647-669, 2011	86	2011
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening IM Al‐masri, MK Mohammad, MO Taha ChemMedChem: Chemistry Enabling Drug Discovery 3 (11), 1763-1779, 2008	82	2008
Combining ligand-based pharmacophore modeling, quantitative structure− activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive … MO Taha, LA Dahabiyeh, Y Bustanji, H Zalloum, S Saleh Journal of medicinal chemistry 51 (20), 6478-6494, 2008	82	2008
Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads A Al-Nadaf, GA Sheikha, MO Taha Bioorganic & medicinal chemistry 18 (9), 3088-3115, 2010	80	2010
Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening MO Taha, N Atallah, AG Al-Bakri, C Paradis-Bleau, H Zalloum, KS Younis, ... Bioorganic & medicinal chemistry 16 (3), 1218-1235, 2008	76	2008
Natural and semisynthetic polymers in pharmaceutical nanotechnology I Dmour, MO Taha Organic materials as smart nanocarriers for drug delivery, 35-100, 2018	75	2018
Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza … AM Abu Hammad, MO Taha Journal of chemical information and modeling 49 (4), 978-996, 2009	73	2009

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori